BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:52 PM
 | 
Apr 02, 2008
 |  BC Extra  |  Top Story

Pfizer ends melanoma trial

Pfizer (NYSE:PFE) discontinued the open-label, Phase III Study A3671009 of tremelimumab monotherapy in advanced melanoma patients after interim data showed the compound...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >